Raloxifene is a medication used to treat postmenopausal osteoporosis and the risk reduction of invasive breast cancer in post-menopausal women. Osteoporosis represents an increased risk for developing fractures. Raloxifene is a selective estrogen receptor modulator with an estrogen-agonistic effect on bone receptors. This activity outlines the indications, action, and contraindications of raloxifene as a valuable agent in the treatment of osteoporosis. In addition, this activity will highlight the mechanism of action, adverse event profile, and dosing pertinent for members of the interprofessional team in patients treated with raloxifene.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/28224
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABOS - 1.0 Point; Credit Type(s): Accredited CME (ABOS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adult Reconstruction, All Practice Areas (e.g. ethics), Complex General Surgical Oncology, Endocrinology, Diabetes, and Metabolism, General Orthopaedics, General Surgery, Geriatric Medicine, Internal Medicine, Medical Oncology, Musculoskeletal Oncology, Orthopaedic Sports Medicine, Orthopaedic Trauma, Rheumatology, Shoulder and Elbow, Surgery of the Hand, Surgery of the Spine
Subscribe
Login
0 Comments
Oldest